2025-520454-11-00招募中1 期
A study to investigate safety, tolerability, pharmacokinetics and efficacy of REM0045392 compared with placebo in healthy participants
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Remynd
- 入组人数
- 52
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
A study to explore the safety, tolerability, pharmacokinetic profile, and potential efficacy of Guanabenz in patients with early childhood onset Vanishing White Matter (VWM)CACH1002929910012303NL-OMON55425Vrije Universiteit Medisch Centrum40
招募中
不适用
Guanabenz in VWMVanishing White Matter (VWM)Childhood ataxia with central nervous system hypomyelination (CACH)NL-OMON24121Amsterdam University Medical Centers, location VUmc, De Boelelaan 1117, 1081HV Amsterdam30
招募中
1 期
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants with Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies.Systemic Lupus Erythematosus2024-519015-34-00AstraZeneca AB24
招募中
1 期
A study evaluating the safety, tolerability, pharmacokinetics, and activity of RO7566802 given alone and in combination with atezolizumab in patients with locally advanced or metastatic solid tumor malignancies2023-509266-38-00Genentech Inc.23
已完成
不适用
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine CarcinomasjRCT2031220511F. Hoffmann-La Roche Ltd168